Rhesus D-negative phenotype and gastric cancer prognosis
Author Information
Author(s): B Mayer, W Schraut, I Funke, KW Jauch, W Mempel, JP Johnson, FW Schildberg
Primary Institution: Klinikum Großhadern, University of Munich
Hypothesis
The Rhesus D-negative phenotype is an independent predictor of poor prognosis in gastric cancer patients.
Conclusion
The Rhesus D-negative phenotype is associated with increased tumor recurrence and reduced overall survival in gastric cancer patients.
Supporting Evidence
- The Rhesus D-negative phenotype was identified in 18.1% of the total gastric cancer collective.
- Rhesus D-negative patients had significantly shorter overall survival times than Rhesus D-positive patients.
- Multivariate analysis showed that the Rhesus D-negative phenotype was a powerful independent predictor of poor prognosis in RO patients.
Takeaway
If a person with gastric cancer has a certain blood type called Rhesus D-negative, they might have a harder time recovering from their illness.
Methodology
The study evaluated the prognostic impact of the Rhesus phenotype in 83 gastric cancer patients undergoing surgical resection, analyzing various clinicopathological factors.
Limitations
Data for some parameters were not available for all patients.
Participant Demographics
The study included 83 gastric cancer patients, with a median age of 67 years.
Statistical Information
P-Value
P=0.0013
Confidence Interval
95% confidence interval for relative risk 9.1 is 2.4-34.9
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website